CEE-03-310 CeNeS Pharmaceuticals

Current Opinion in Investigational Drugs

Volumn 3, Issue 2, 2002, Pages 284-288

  Eder, Derek N ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2,3 DIHYDROBENZOFURAN 7 YL) 2,3,4,5 TETRAHYDRO 3 METHYL 8 NITRO 1H 3 BENZAZEPIN 7 OL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; 8 CHLORO 5 (2,3 DIHYDROBENZOFURAN 7 YL) 2,3,4,5 TETRAHYDRO 3 METHYL 1H 3 BENZAZEPIN 7 OL; CEE 03 310; CLORAZEPATE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; FLURAZEPAM; NNC 01 687; NO 687; UNCLASSIFIED DRUG; ZOLPIDEM; ZOPICLONE;

ALCOHOLISM; CLINICAL TRIAL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG MECHANISM; DRUG METABOLISM; DRUG SYNTHESIS; FATIGUE; HUMAN; NAUSEA; NEUROLOGIC DISEASE; NONHUMAN; RESTLESSNESS; REVIEW; SCHIZOPHRENIA; SLEEP DISORDER; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING;

ALCOHOLISM; ANIMALS; BENZAZEPINES; BENZOFURANS; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; DOPAMINE ANTAGONISTS; DRUGS, INVESTIGATIONAL; HUMANS; LETHAL DOSE 50; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, DOPAMINE D1; SLEEP INITIATION AND MAINTENANCE DISORDERS; STRUCTURE-ACTIVITY RELATIONSHIP; TREATMENT OUTCOME;

EID: 0036228373     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Differentiating the effects of three benzodiazepines on non-REM sleep EEG spectra. A neural-network pattern classification analysis
2. Effect of zolpidem on sleep and sleep EEG spectra in healthy young men
3. 1 receptor antagonists
4. 1 receptor ligands. Preparation, autoradiography and PET investigation in monkey
5. 1-dopamine receptor
6. 1 receptor antagonists
7. 1 antagonist NNC 01-0687 in healthy subjects
8. CeNeS acquires rights from Novo Nordisk to develop new schizophrenia therapies
9. 1-like dopaminergic receptors
10. Dopamine receptors: From structure to function
11. Drug development pipeline: CEE-03-320 and CEE-03-310
12. Merger with CeNeS Limited
13. 1 antagonist, NNC 01-0687, on unstimulated and stimulated release of anterior pituitary hormones in males
14. Interim results for the six months ended 30 June 2000
15. New CeNeS drug aims to combat substance abuse
16. 1 receptor antagonist (NNC-687)
17. 5 and γ-aminobutyric acid A receptors
18. 1 receptor interaction in rat brain limbic regions but not basal ganglia
19. 1-like receptors by NNC 01-0012
20. A receptors in the regulation of sleep: Initial sleep responses to peripherally administered modulators and agonists
21. Pattern recognition by matched filtering: An analysis of sleep spindle and K-complex density under the influence of lormetazepam and zopiclone
22. Modulation of delta activity by hypnotics in middle-aged subjects: Studies with a benzodiazepine (flurazepam) and a cyclopyrrolone (zopiclone)
23. Network modulation of a slow intrinsic oscillation of cat thalamocortical neurons implicated in sleep delta waves: Cortically induced synchronization and brainstem cholinergic suppression
24. 2 dopamine receptor subtypes
25. 1 dopamine receptor neurons
26. 5 dopamine receptors in primate brain
27. Dopamine receptor subtypes modulate olfactory bulb γ-aminobutyric acid type A receptors
28. 1 receptor interactions in the basal ganglia
29. 2 interactions and non-synaptic influences
30. Flupenthixol as a potential pharmacotreatment of alcohol and cocaine abuse/dependence
31. Effects of haloperidol or SCH-23390 on ethanol-induced conditioned taste aversion
32. Alcohol self-administration: Further examination of the role of dopamine receptors in the nucleus accumbens
33. 1 receptor gene expression attenuates alcohol-seeking behavior
34. CeNeS Pharmaceuticals Plc. Preliminary results for the year ending 31st December 2000